Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Truelsen

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Ugeskrift for Laeger|June 14, 2021
[Challenges and advances in paediatric arterial ischaemic stroke]Julie Brix Bindslev, Thomas Truelsen, Mette Gyhrs, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 22, 2014
Testing devices for the prevention and treatment of stroke and its complicationsPhilip M Bath, Michael Brainin, Chloe Brown, et al.
The Lancet. Neurology|May 5, 2015
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trialGregory W Albers, Rüdiger von Kummer, Thomas Truelsen, et al.
European Journal of Radiology|September 3, 2025
Accuracy of detecting critical findings using abbreviated brain MRI scan protocols as a prerequisite for AI-driven on-the-fly scan protocol adaptationKaining Sheng, Silvia Ingala, Andreas Hjelm Brandt, et al.
Stroke|November 3, 2016
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)Rüdiger von Kummer, Etsuro Mori, Thomas Truelsen, et al.
Lancet (London, England)|January 23, 2014
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010Valery L Feigin, Mohammad H Forouzanfar, Rita Krishnamurthi, et al.
The Lancet. Global Health|August 9, 2014
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010Rita V Krishnamurthi, Valery L Feigin, Mohammad H Forouzanfar, et al.
Neuroepidemiology|October 28, 2015
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 StudyValery L Feigin, Rita V Krishnamurthi, Priya Parmar, et al.
Lancet (London, England)|June 22, 2010
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control studyMartin J O'Donnell, Denis Xavier, Lisheng Liu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 13, 2013
Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and designLuciano A Sposato, Mariano L Coppola, Juan Altamirano, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Ugeskrift for Laeger|June 14, 2021
[Challenges and advances in paediatric arterial ischaemic stroke]Julie Brix Bindslev, Thomas Truelsen, Mette Gyhrs, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 22, 2014
Testing devices for the prevention and treatment of stroke and its complicationsPhilip M Bath, Michael Brainin, Chloe Brown, et al.
The Lancet. Neurology|May 5, 2015
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trialGregory W Albers, Rüdiger von Kummer, Thomas Truelsen, et al.
European Journal of Radiology|September 3, 2025
Accuracy of detecting critical findings using abbreviated brain MRI scan protocols as a prerequisite for AI-driven on-the-fly scan protocol adaptationKaining Sheng, Silvia Ingala, Andreas Hjelm Brandt, et al.
Stroke|November 3, 2016
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke)Rüdiger von Kummer, Etsuro Mori, Thomas Truelsen, et al.
Lancet (London, England)|January 23, 2014
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010Valery L Feigin, Mohammad H Forouzanfar, Rita Krishnamurthi, et al.
The Lancet. Global Health|August 9, 2014
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010Rita V Krishnamurthi, Valery L Feigin, Mohammad H Forouzanfar, et al.
Neuroepidemiology|October 28, 2015
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 StudyValery L Feigin, Rita V Krishnamurthi, Priya Parmar, et al.
Lancet (London, England)|June 22, 2010
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control studyMartin J O'Donnell, Denis Xavier, Lisheng Liu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 13, 2013
Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and designLuciano A Sposato, Mariano L Coppola, Juan Altamirano, et al.
Pageof 8